Stay updated with breaking news from Nasal epinephrine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Share: ResearchAndMarkets.com s offering. The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements. The patent expiry of biologics is also expected to provide growth opportunities for players in the market. On the other hand, the preference for alternative routes of drug delivery such as oral diabetic agents and nasal epinephrine sprays is expected to limit the adoption of autoinjector devices. ....